Related references
Note: Only part of the references are listed.Adherence to oral chemotherapy: Challenges and opportunities
Susan Krikorian et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2019)
Development of a Smartphone Program to Support Adherence to Oral Chemotherapy in People with Cancer
Xiomara Skrabal Ross et al.
PATIENT PREFERENCE AND ADHERENCE (2019)
Interventions to Improve Oral Chemotherapy Safety and Quality A Systematic Review
Jessica A. Zerillo et al.
JAMA ONCOLOGY (2018)
Predictive factors of treatment adherence in cancer outpatients
Manuela Polidoro Lima et al.
PSYCHO-ONCOLOGY (2018)
Structured approaches to promote patient and family engagement in treatment in acute care hospital settings: protocol for a systematic scoping review
Donna Goodridge et al.
SYSTEMATIC REVIEWS (2018)
Possible associations of personality traits representing harm avoidance and self-directedness with medication adherence in Japanese patients with type 2 diabetes
Yoshiko Tominaga et al.
JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES (2018)
Sorafenib: A Review in Hepatocellular Carcinoma
Gillian M. Keating
TARGETED ONCOLOGY (2017)
Impact of clinical pharmacists in outpatient oncology practices: A review
Justin Gatwood et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2017)
Prevalence and associated factors of medication non-adherence in hematological-oncological patients in their home situation
Linda Bouwman et al.
BMC CANCER (2017)
A trial examining an advanced practice nurse intervention to promote medication adherence and symptom management in adult cancer patients prescribed oral anti-cancer agents: study protocol
Sandra L. Spoelstra et al.
JOURNAL OF ADVANCED NURSING (2016)
To adhere or not to adhere: Rates and reasons of medication adherence in hematological cancer patients
Alix E. Hall et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Influence of patient personality in the treatment of rheumatoid arthritis
Leticia Leon et al.
RHEUMATOLOGY INTERNATIONAL (2016)
Medication adherence to oral cancer therapy: The promising role of the pharmacist
Maria A. Felton et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2016)
Role of pharmacist counseling in pharmacotherapy quality improvement
Yalda Sanii et al.
JOURNAL OF RESEARCH IN PHARMACY PRACTICE (2016)
2013 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards Including Standards for the Safe Administration and Management of Oral Chemotherapy
Michael N. Neuss et al.
JOURNAL OF ONCOLOGY PRACTICE (2013)
Two character traits associated with adherence to long term therapies
Gerard Reach
DIABETES RESEARCH AND CLINICAL PRACTICE (2012)
Randomized Phase II Trial of Sunitinib on an Intermittent Versus Continuous Dosing Schedule As First-Line Therapy for Advanced Renal Cell Carcinoma
Robert J. Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell et al.
LANCET ONCOLOGY (2012)
Medication Adherence: WHO Cares?
Marie T. Brown et al.
MAYO CLINIC PROCEEDINGS (2011)
Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care
Sven Simons et al.
SUPPORTIVE CARE IN CANCER (2011)
Personality and medication non-adherence among older adults enrolled in a six-year trial
Anthony Jerant et al.
BRITISH JOURNAL OF HEALTH PSYCHOLOGY (2011)
Moderators of the Negative Effects of Catastrophizing in Arthritis
Robert R. Edwards et al.
PAIN MEDICINE (2010)
Patient Adherence and Persistence With Oral Anticancer Treatment
Kathryn Ruddy et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
A routine feasible HPLC analysis for the anti-angiogenic tyrosine kinase inhibitor, sunitinib, and its main metabolite, SU12662, in plasma
Marie-Christine Etienne-Grimaldi et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2009)
Validation of an HPLC-UV method for sorafenib determination in human plasma and application to cancer patients in routine clinical practice
B. Blanchet et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2009)
Depression in lung cancer patients: is the HADS an effective screening tool?
Lorys Castelli et al.
SUPPORTIVE CARE IN CANCER (2009)
Fear of pain, pain catastrophizing, and acute pain perception: Relative prediction and timing of assessment
Adam T. Hirsh et al.
JOURNAL OF PAIN (2008)
Medication compliance and persistence: Terminology and definitions
Joyce A. Cramer et al.
VALUE IN HEALTH (2008)
A phase I and pharmacokinetic study of sunitinib administered daily for 2 weeks, followed by a 1-week off period
Carolyn D. Britten et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours
A Awada et al.
BRITISH JOURNAL OF CANCER (2005)
Styles of coping with cancer: The Italian version of the mini-mental adjustment to cancer (Mini-MAC) scale
L Grassi et al.
PSYCHO-ONCOLOGY (2005)
Temperament, character, and attachment patterns in borderline personality disorder
A Fossati et al.
JOURNAL OF PERSONALITY DISORDERS (2001)
Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies
M Hidalgo et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
